Amgen (AMGN): No Conclusion on Sensipar's Role in Death, Still Working with FDA
Go back to Amgen (AMGN): No Conclusion on Sensipar's Role in Death, Still Working with FDA| Amgen Inc (NASDAQ: AMGN) | Delayed: 415.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $415.21 | 52 Week High | $176.85 | |||
| Open | $415.21 | 52 Week Low | $133.64 | |||
| Day High | $415.21 | P/E | 62.53 | |||
| Day Low | $415.21 | EPS | $6.64 | |||
| Volume | 1,703 | |||||
